Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | |
| Cash Flows From Operating Activities | |
| Net Income | -19,005 |
| Depreciation Amortization | 2,630 |
| Accounts payable and accrued liabilities | 489 |
| Other Working Capital | 4,460 |
| Other Operating Activity | -453 |
| Operating Cash Flow | $-11,879 |
| Cash Flows From Investing Activities | |
| PPE Investments | -1,667 |
| Purchase Of Investment | -36,894 |
| Sale Of Investment | 44,311 |
| Investing Cash Flow | $5,750 |
| Cash Flows From Financing Activities | |
| Debt Issued | 3,015 |
| Debt Repayment | -2,794 |
| Common Stock Issued | 67 |
| Financing Cash Flow | $288 |
| Beginning Cash Position | 16,318 |
| End Cash Position | 10,478 |
| Net Cash Flow | $-5,841 |
| Free Cash Flow | |
| Operating Cash Flow | -11,879 |
| Capital Expenditure | -1,667 |
| Free Cash Flow | -13,546 |